Index RUT
P/E -
EPS (ttm) -0.52
Insider Own 9.11%
Shs Outstand 76.55M
Perf Week -5.85%
Market Cap 1.34B
Forward P/E 9.02
EPS next Y 1.94
Insider Trans -0.86%
Shs Float 69.53M
Perf Month -27.32%
Income -38.77M
PEG -
EPS next Q 0.32
Inst Own 97.12%
Short Float 7.95%
Perf Quarter -25.97%
Sales 10.42B
P/S 0.13
EPS this Y 14.51%
Inst Trans -1.26%
Short Ratio 8.22
Perf Half Y -9.36%
Book/sh 11.71
P/B 1.50
EPS next Y 24.82%
ROA -0.74%
Short Interest 5.53M
Perf Year -11.46%
Cash/sh 3.54
P/C 4.95
EPS next 5Y 18.50%
ROE -4.26%
52W Range 13.64 - 28.35
Perf YTD -9.03%
Dividend Est. -
P/FCF 3.96
EPS past 5Y 40.46%
ROI -1.24%
52W High -38.17%
Beta 0.31
Dividend TTM -
Quick Ratio 0.56
Sales past 5Y 2.16%
Gross Margin 17.97%
52W Low 28.52%
ATR (14) 1.03
Dividend Ex-Date Dec 14, 2021
Current Ratio 1.16
EPS Y/Y TTM 6.91%
Oper. Margin 2.23%
RSI (14) 32.95
Volatility 4.04% 5.88%
Employees 22200
Debt/Eq 2.72
Sales Y/Y TTM 3.50%
Profit Margin -0.37%
Recom 3.14
Target Price 22.57
Option/Short Yes / Yes
LT Debt/Eq 2.48
EPS Q/Q 11.70%
Payout -
Rel Volume 0.00
Prev Close 17.53
Sales Surprise 0.12%
EPS Surprise 6.15%
Sales Q/Q 3.56%
Earnings May 03 BMO
Avg Volume 672.94K
Price 17.53
SMA20 -11.20%
SMA50 -25.04%
SMA200 -12.61%
Trades
Volume 0
Change 0.00%
Date
Action
Analyst
Rating Change
Price Target Change
Feb-26-24 Initiated
Leerink Partners
Market Perform
$24
Jan-03-24 Initiated
Barclays
Equal Weight
$21
Oct-13-22 Downgrade
Citigroup
Buy → Neutral
$52 → $18
Oct-12-22 Downgrade
Robert W. Baird
Outperform → Neutral
$62 → $22
Oct-12-22 Downgrade
BofA Securities
Buy → Underperform
$43 → $17
Apr-26-22 Resumed
Citigroup
Buy
$55
Apr-01-22 Resumed
Credit Suisse
Neutral
$43
Mar-30-22 Resumed
JP Morgan
Underweight
$46
Dec-17-20 Upgrade
UBS
Neutral → Buy
$27 → $37
Sep-25-20 Upgrade
Barclays
Underweight → Equal Weight
$20
Jul-21-20 Upgrade
Robert W. Baird
Neutral → Outperform
$8 → $14
Jul-21-20 Upgrade
BofA Securities
Neutral → Buy
$8 → $12
May-05-20 Downgrade
Robert W. Baird
Outperform → Neutral
$8
Apr-23-20 Resumed
Credit Suisse
Neutral
$8
Jan-21-20 Upgrade
Robert W. Baird
Neutral → Outperform
$9
Sep-06-19 Reiterated
BofA/Merrill
Neutral
$4 → $7.50
Apr-10-19 Reiterated
BofA/Merrill
Neutral
$7 → $4.50
Jan-17-19 Initiated
UBS
Neutral
$8
Nov-01-18 Reiterated
Barclays
Underweight
$12 → $8
Oct-31-18 Downgrade
BofA/Merrill
Buy → Neutral
Show Previous Ratings
May-13-24 06:30AM
May-06-24 09:40AM
09:13AM
May-04-24 08:28AM
03:01AM
10:41PM
Loading…
May-03-24 10:41PM
(Thomson Reuters StreetEvents) -25.70%
04:08PM
02:56PM
10:53AM
09:30AM
09:13AM
07:51AM
06:41AM
(Associated Press Finance)
06:30AM
Apr-30-24 11:03AM
06:30AM
Loading…
Apr-22-24 06:30AM
Apr-13-24 12:18PM
Apr-02-24 10:28AM
Mar-04-24 01:35PM
Feb-26-24 09:15AM
Feb-23-24 09:40AM
Feb-21-24 08:39AM
Feb-20-24 10:44PM
(Thomson Reuters StreetEvents)
03:00PM
07:40AM
07:04AM
06:51AM
06:48AM
(Associated Press Finance)
06:30AM
Feb-08-24 04:15PM
09:40AM
Loading…
Jan-17-24 09:40AM
Dec-07-23 06:45AM
Dec-06-23 07:00AM
Nov-29-23 06:30AM
Nov-23-23 03:03AM
Nov-13-23 11:03PM
Nov-03-23 09:24PM
(Thomson Reuters StreetEvents) +27.08%
08:45AM
08:14AM
06:07AM
(Associated Press Finance)
06:00AM
Oct-24-23 04:30PM
Oct-23-23 06:30AM
Oct-18-23 08:50AM
Oct-02-23 07:33PM
Sep-27-23 04:30PM
Sep-26-23 08:32AM
Aug-23-23 08:38AM
Aug-08-23 07:27AM
Aug-05-23 08:38AM
Aug-04-23 07:45AM
06:41AM
(Associated Press Finance)
06:30AM
Jul-21-23 06:30AM
Jun-22-23 06:30AM
Jun-21-23 08:00PM
May-10-23 10:23AM
May-09-23 06:08AM
May-08-23 06:30AM
May-05-23 10:19PM
(Thomson Reuters StreetEvents) +37.49%
01:04PM
07:45AM
06:41AM
06:30AM
May-04-23 08:20AM
Apr-26-23 08:00PM
09:46AM
Apr-24-23 04:30PM
Apr-23-23 08:30AM
Mar-09-23 09:21AM
Mar-01-23 05:00PM
05:24AM
05:19AM
Feb-28-23 09:51PM
(Thomson Reuters StreetEvents) -21.83%
11:24AM
07:25AM
06:05AM
Feb-21-23 10:00AM
Feb-15-23 06:30PM
10:00AM
Feb-10-23 01:43PM
Feb-09-23 02:10AM
Feb-08-23 10:50AM
Jan-11-23 07:25AM
Dec-02-22 07:24AM
Nov-16-22 04:45PM
Nov-07-22 06:30AM
Nov-05-22 08:17AM
Nov-04-22 07:50PM
Nov-02-22 08:05AM
06:45AM
Oct-27-22 10:02AM
Oct-26-22 10:02AM
Oct-25-22 06:30AM
Oct-14-22 06:41PM
05:39PM
12:32PM
Oct-12-22 09:25AM
06:45AM
Oct-04-22 05:33PM
Owens & Minor, Inc. is a healthcare solutions company, which engages in the product manufacturing and delivery, home health supply, and perioperative services to support care through the hospital and into the home. It operates through the Products and Healthcare Services, and Patient Direct segments. The Products and Healthcare Services segment includes medical distribution, the outsourced logistics and value-added services business, and global products, which manufacture and source medical surgical products through the production and kitting operations. The Patient Direct segments includes the home healthcare business, Byram and Apria. The company was founded by Otho O. Owens and G. Gilmer Minor in 1882 and is headquartered in Mechanicsville, VA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Galloway Heath H EVP,General Counsel & CorpSecy May 17 '24 Sale 19.06 2,052 39,111 54,846 May 20 08:11 AM Galloway Heath H EVP,General Counsel & CorpSecy May 16 '24 Sale 20.18 2,031 40,986 56,898 May 20 08:11 AM Bernocchi Perry A EVP, CEO,. Patient Direct May 01 '24 Sale 24.31 24,094 585,680 170,497 May 03 04:03 PM Leon Jonathan A SVP, Corporate Treasurer Apr 22 '24 Sale 24.84 5,000 124,200 84,673 Apr 23 06:00 PM Lowry Michael Wayne SVP, Corporate Controller Feb 27 '24 Sale 25.00 10,000 250,000 71,654 Feb 28 08:00 PM Leon Jonathan A SVP, Corporate Treasurer Feb 20 '24 Sale 22.00 5,000 110,000 75,713 Feb 22 04:15 PM Galloway Heath H EVP,General Counsel & CorpSecy Feb 07 '24 Sale 19.91 97 1,931 36,437 Feb 08 04:01 PM Leon Jonathan A SVP, Corporate Treasurer Jan 17 '24 Sale 18.08 7,500 135,600 83,213 Jan 18 08:52 AM Leon Jonathan A SVP, Corporate Treasurer Dec 20 '23 Sale 21.34 5,000 106,700 93,213 Dec 21 09:41 PM Bernocchi Perry A EVP, CEO,. Patient Direct Nov 22 '23 Sale 18.75 19,302 361,916 164,347 Nov 22 09:50 PM Leon Jonathan A SVP, Corporate Treasurer Nov 20 '23 Sale 18.62 5,000 93,100 98,213 Nov 21 08:18 AM Bruni Alexander J EVP, CFO Nov 10 '23 Sale 17.57 12,668 222,577 41,457 Nov 13 07:02 PM Galloway Heath H EVP,General Counsel & CorpSecy Nov 10 '23 Sale 17.57 5,500 96,635 36,479 Nov 13 07:02 PM Pesicka Edward A President & CEO Jun 16 '23 Sale 19.28 38,780 747,487 708,373 Jun 20 08:55 AM Pesicka Edward A President & CEO Jun 15 '23 Sale 19.24 38,780 746,097 747,153 Jun 20 08:55 AM Pesicka Edward A President & CEO Jun 09 '23 Sale 20.79 118,928 2,472,941 785,933 Jun 12 04:23 PM Pesicka Edward A President & CEO Jun 08 '23 Sale 21.19 118,928 2,520,120 904,861 Jun 12 04:23 PM Pesicka Edward A President & CEO Jun 07 '23 Sale 21.56 118,927 2,564,554 1,023,789 Jun 08 05:06 PM Pesicka Edward A President & CEO Jun 06 '23 Sale 20.86 118,927 2,480,544 1,142,716 Jun 08 05:06 PM Lowry Michael Wayne SVP, Corporate Controller Jun 06 '23 Sale 21.11 10,000 211,100 80,360 Jun 08 05:07 PM
Index S&P 500
P/E 24.24
EPS (ttm) 2.96
Insider Own 1.18%
Shs Outstand 129.25M
Perf Week -3.86%
Market Cap 9.18B
Forward P/E 12.81
EPS next Y 5.60
Insider Trans -5.40%
Shs Float 126.53M
Perf Month -1.51%
Income 388.00M
PEG 4.85
EPS next Q 1.24
Inst Own 101.60%
Short Float 4.20%
Perf Quarter -10.98%
Sales 12.45B
P/S 0.74
EPS this Y 12.88%
Inst Trans 0.52%
Short Ratio 4.87
Perf Half Y 3.34%
Book/sh 28.02
P/B 2.56
EPS next Y 10.19%
ROA 4.15%
Short Interest 5.31M
Perf Year -5.08%
Cash/sh 1.24
P/C 57.76
EPS next 5Y 5.00%
ROE 10.97%
52W Range 60.01 - 82.63
Perf YTD -5.27%
Dividend Est. -
P/FCF 19.42
EPS past 5Y -1.96%
ROI 6.60%
52W High -13.20%
Beta 0.90
Dividend TTM -
Quick Ratio 1.02
Sales past 5Y 5.89%
Gross Margin 29.56%
52W Low 19.51%
ATR (14) 1.49
Dividend Ex-Date -
Current Ratio 1.75
EPS Y/Y TTM -15.83%
Oper. Margin 5.22%
RSI (14) 46.31
Volatility 1.80% 2.20%
Employees 25000
Debt/Eq 0.76
Sales Y/Y TTM -0.61%
Profit Margin 3.12%
Recom 2.67
Target Price 79.92
Option/Short Yes / Yes
LT Debt/Eq 0.63
EPS Q/Q -21.21%
Payout 0.00%
Rel Volume 0.00
Prev Close 71.72
Sales Surprise -1.05%
EPS Surprise 8.23%
Sales Q/Q 3.66%
Earnings May 07 BMO
Avg Volume 1.09M
Price 71.72
SMA20 -0.29%
SMA50 -1.04%
SMA200 -1.60%
Trades
Volume 0
Change 0.00%
Date
Action
Analyst
Rating Change
Price Target Change
Feb-26-24 Initiated
Leerink Partners
Market Perform
$78
Dec-12-23 Upgrade
JP Morgan
Neutral → Overweight
$71 → $82
Nov-10-23 Upgrade
Stifel
Hold → Buy
$70
Aug-08-22 Upgrade
UBS
Sell → Neutral
$80
Jul-21-22 Downgrade
Goldman
Buy → Neutral
$93 → $85
Jun-14-22 Downgrade
Robert W. Baird
Outperform → Neutral
$103 → $88
May-13-22 Resumed
Credit Suisse
Outperform
$100
Jan-31-22 Initiated
Morgan Stanley
Underweight
$67
Jan-07-22 Upgrade
Credit Suisse
Neutral → Outperform
$78 → $90
Oct-01-21 Resumed
Credit Suisse
Neutral
$78
Feb-08-21 Resumed
Piper Sandler
Overweight
$83
Jan-04-21 Upgrade
Robert W. Baird
Neutral → Outperform
$70 → $79
Nov-03-20 Upgrade
Barrington Research
Mkt Perform → Outperform
$72
May-06-20 Downgrade
Barrington Research
Outperform → Mkt Perform
Apr-07-20 Upgrade
Goldman
Neutral → Buy
$64 → $59
Apr-02-20 Upgrade
Wolfe Research
Peer Perform → Outperform
$68
Jan-09-20 Downgrade
BofA/Merrill
Neutral → Underperform
Jan-02-20 Upgrade
Evercore ISI
Underperform → In-line
$61 → $70
Aug-07-19 Downgrade
William Blair
Outperform → Mkt Perform
May-30-19 Initiated
Wolfe Research
Underperform
Show Previous Ratings
May-27-24 09:40AM
May-21-24 06:30AM
May-20-24 09:50AM
May-17-24 08:10AM
06:30AM
08:41AM
Loading…
May-16-24 08:41AM
May-15-24 09:06AM
May-13-24 10:40AM
06:30AM
May-08-24 12:54PM
10:23AM
09:40AM
07:40AM
06:19AM
03:28AM
01:14AM
Loading…
01:14AM
(Thomson Reuters StreetEvents)
May-07-24 10:55AM
09:30AM
08:58AM
08:06AM
07:32AM
07:10AM
06:38AM
06:09AM
(Associated Press Finance)
06:00AM
May-02-24 09:15AM
Apr-29-24 06:30AM
Apr-23-24 06:30AM
Apr-22-24 08:42AM
06:30AM
06:30AM
Loading…
Apr-18-24 06:30AM
Apr-17-24 11:07AM
07:46AM
Apr-11-24 06:30AM
Apr-10-24 04:05PM
Apr-05-24 07:17AM
Apr-04-24 06:30AM
Apr-02-24 10:13AM
08:01AM
Apr-01-24 05:34AM
Mar-31-24 12:51AM
Mar-28-24 11:30AM
Mar-21-24 07:00PM
Mar-19-24 07:00PM
Mar-10-24 10:08AM
Mar-06-24 11:55PM
Mar-04-24 06:30AM
Feb-28-24 09:09AM
02:21AM
(Thomson Reuters StreetEvents)
Feb-27-24 09:30AM
08:44AM
07:32AM
07:10AM
06:32AM
06:18AM
(Associated Press Finance)
06:00AM
05:30AM
Feb-22-24 09:15AM
06:30AM
Feb-21-24 06:30AM
Feb-19-24 08:00AM
Feb-16-24 08:38AM
Feb-14-24 06:30AM
Feb-07-24 09:00AM
Feb-01-24 09:32AM
Jan-25-24 07:00AM
Jan-23-24 08:57AM
06:30AM
Jan-03-24 06:30AM
Dec-27-23 10:09AM
Dec-23-23 07:01PM
Dec-21-23 11:39AM
Dec-20-23 07:00AM
Dec-18-23 04:12PM
Dec-15-23 06:30AM
Dec-13-23 11:30AM
Dec-08-23 07:25AM
Dec-05-23 07:37AM
Dec-04-23 02:00AM
Dec-03-23 04:00PM
Nov-30-23 06:29AM
Nov-28-23 06:30AM
Nov-16-23 05:10PM
Nov-14-23 01:19PM
07:20AM
05:50AM
(Thomson Reuters StreetEvents)
Nov-13-23 05:25PM
04:50PM
03:56PM
12:37PM
10:59AM
09:30AM
07:15AM
07:00AM
06:58AM
06:07AM
(Associated Press Finance)
06:00AM
06:00AM
Nov-10-23 11:50AM
Nov-08-23 04:00PM
Henry Schein, Inc. engages in the provision of health care products and services to medical, dental, and veterinary office-based practitioners. It operates through the Healthcare Distribution and Technology and Value-Added Services segments. The Healthcare Distribution segment includes consumable products, laboratory, small and large equipment repair services, branded and generic pharmaceuticals, vaccines, surgical, diagnostic tests, infection-control products, and vitamins. The Technology and Value-Added Services segment offers financial on a non-recourse basis, network, and hardware services. The company was founded by Henry Schein and Esther Schein in 1932 and is headquartered in Melville, NY.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Connett Bradford C CEO, NA Distribution Group Mar 20 '24 Sale 74.28 6,430 477,620 73,108 Mar 21 04:18 PM BRESLAWSKI JAMES P Vice Chairman, President Mar 18 '24 Sale 74.37 2,907 216,194 209,562 Mar 19 04:11 PM LASKAWY PHILIP A Director Mar 05 '24 Sale 76.29 4,278 326,369 24,565 Mar 06 04:54 PM BRESLAWSKI JAMES P Vice Chairman, President Mar 04 '24 Sale 76.50 2,907 222,386 212,469 Mar 05 04:27 PM KUEHN KURT P Director Mar 01 '24 Sale 77.07 1,582 121,925 13,598 Mar 05 04:52 PM BERGMAN STANLEY M Chairman, CEO Dec 26 '23 Sale 75.14 13,962 1,049,105 168,633 Dec 27 04:10 PM BERGMAN STANLEY M Chairman, CEO Dec 26 '23 Sale 75.14 5,820 437,315 481,450 Dec 27 04:10 PM BERGMAN STANLEY M Chairman, CEO Dec 22 '23 Sale 75.03 26,190 1,965,036 182,595 Dec 27 04:10 PM BERGMAN STANLEY M Chairman, CEO Dec 22 '23 Sale 75.03 10,914 818,877 487,270 Dec 27 04:10 PM Connett Bradford C CEO, NA Distribution Group Dec 21 '23 Sale 74.02 11,238 831,837 57,831 Dec 22 04:02 PM Brous David B Jr CEO, Strategic Business Group Jun 12 '23 Sale 74.86 11,157 835,191 68,690 Jun 13 04:35 PM Siegel Walter Sr. VP & Chief Legal Officer Jun 05 '23 Sale 74.07 5,497 407,163 35,737 Jun 07 04:07 PM BRESLAWSKI JAMES P Vice Chairman, President Jun 02 '23 Sale 74.29 24,234 1,800,453 201,555 Jun 06 04:04 PM
Index RUT
P/E 11.81
EPS (ttm) 2.03
Insider Own 11.35%
Shs Outstand 96.35M
Perf Week -7.07%
Market Cap 2.14B
Forward P/E 9.84
EPS next Y 2.43
Insider Trans -0.04%
Shs Float 79.43M
Perf Month -7.21%
Income 193.86M
PEG 1.31
EPS next Q 0.83
Inst Own 87.49%
Short Float 4.19%
Perf Quarter -17.33%
Sales 6.57B
P/S 0.33
EPS this Y -4.26%
Inst Trans -1.29%
Short Ratio 4.09
Perf Half Y -25.91%
Book/sh 10.78
P/B 2.22
EPS next Y 5.00%
ROA 6.59%
Short Interest 3.33M
Perf Year -9.90%
Cash/sh 1.38
P/C 17.30
EPS next 5Y 9.00%
ROE 18.71%
52W Range 23.63 - 34.53
Perf YTD -15.85%
Dividend Est. 1.07 (4.47%)
P/FCF -
EPS past 5Y -0.34%
ROI 12.92%
52W High -30.67%
Beta 1.05
Dividend TTM 1.04 (4.34%)
Quick Ratio 0.72
Sales past 5Y 3.92%
Gross Margin 21.30%
52W Low 1.31%
ATR (14) 0.57
Dividend Ex-Date Apr 18, 2024
Current Ratio 1.43
EPS Y/Y TTM 0.82%
Oper. Margin 4.33%
RSI (14) 30.89
Volatility 2.55% 2.07%
Employees 7600
Debt/Eq 0.92
Sales Y/Y TTM 2.78%
Profit Margin 2.95%
Recom 2.69
Target Price 29.55
Option/Short Yes / Yes
LT Debt/Eq 0.54
EPS Q/Q -6.32%
Payout 49.01%
Rel Volume 0.00
Prev Close 23.94
Sales Surprise -0.35%
EPS Surprise -1.22%
Sales Q/Q 0.95%
Earnings Feb 28 BMO
Avg Volume 812.13K
Price 23.94
SMA20 -5.74%
SMA50 -7.96%
SMA200 -16.56%
Trades
Volume 0
Change 0.00%
Date
Action
Analyst
Rating Change
Price Target Change
Feb-29-24 Downgrade
Piper Sandler
Overweight → Neutral
$34 → $28
Feb-26-24 Initiated
Leerink Partners
Outperform
$36
May-13-22 Resumed
Credit Suisse
Outperform
$36
Jan-31-22 Initiated
Morgan Stanley
Equal-Weight
$30
Oct-01-21 Resumed
Credit Suisse
Outperform
$38
Jun-17-21 Upgrade
Piper Sandler
Neutral → Overweight
$34 → $44
Nov-10-20 Downgrade
Guggenheim
Buy → Neutral
Jul-07-20 Resumed
Piper Sandler
Neutral
$22
Jun-25-20 Upgrade
Goldman
Sell → Neutral
$11 → $21
Apr-02-20 Upgrade
Wolfe Research
Underperform → Peer Perform
Feb-28-20 Upgrade
JP Morgan
Underweight → Neutral
$20 → $25
Feb-27-20 Upgrade
BofA/Merrill
Neutral → Buy
Jan-09-20 Upgrade
BofA/Merrill
Underperform → Neutral
$19.50 → $22.50
Jan-07-20 Upgrade
Guggenheim
Neutral → Buy
$25
Dec-18-19 Upgrade
CFRA
Strong Sell → Hold
May-30-19 Initiated
Wolfe Research
Underperform
Apr-18-19 Initiated
Guggenheim
Neutral
Jan-17-19 Initiated
UBS
Neutral
$23
Jan-03-19 Upgrade
Evercore ISI
Underperform → In-line
Oct-19-18 Resumed
Goldman
Sell
Show Previous Ratings
May-23-24 09:01AM
May-10-24 07:00AM
Apr-10-24 01:22PM
Mar-27-24 01:57PM
Mar-22-24 09:23AM
08:04PM
Loading…
Mar-11-24 08:04PM
Mar-01-24 08:06PM
Feb-29-24 11:44AM
09:00AM
Feb-28-24 09:30AM
07:00AM
Feb-26-24 11:38AM
Feb-21-24 06:12PM
Feb-02-24 08:00AM
Jan-17-24 05:12AM
02:43PM
Loading…
Jan-16-24 02:43PM
Jan-03-24 08:41AM
(Investor's Business Daily)
Jan-02-24 06:21PM
Dec-29-23 11:30AM
Dec-06-23 04:30PM
Dec-01-23 09:49AM
08:59AM
Nov-30-23 04:10AM
Nov-29-23 10:22PM
(Thomson Reuters StreetEvents) -17.24%
10:16AM
08:50AM
07:11AM
07:00AM
Nov-27-23 06:05AM
Nov-22-23 08:28AM
04:30PM
Loading…
Nov-21-23 04:30PM
Nov-20-23 04:29PM
Nov-17-23 09:40AM
Nov-06-23 12:18PM
08:44AM
Nov-03-23 09:50AM
Nov-02-23 09:40AM
Oct-29-23 05:35PM
Oct-25-23 05:20AM
Oct-18-23 07:07AM
Oct-13-23 11:36AM
Oct-09-23 09:50AM
Oct-04-23 08:08PM
Sep-29-23 11:30AM
Sep-26-23 07:36AM
Sep-12-23 04:30PM
Sep-04-23 09:40AM
Aug-31-23 08:59AM
Aug-30-23 11:06PM
(Thomson Reuters StreetEvents) -7.77%
01:30PM
12:46PM
12:29PM
09:40AM
07:00AM
Aug-29-23 12:15PM
08:38AM
Aug-28-23 11:07AM
10:41AM
10:40AM
10:40AM
09:55AM
Aug-25-23 08:04AM
08:02AM
Aug-24-23 11:26AM
09:13AM
Aug-23-23 04:30PM
01:03PM
10:23AM
09:40AM
05:58AM
Aug-22-23 01:05PM
10:30AM
10:28AM
Aug-21-23 01:01PM
11:48AM
09:40AM
Aug-18-23 01:05PM
01:01PM
12:41PM
12:35PM
Aug-17-23 01:02PM
11:21AM
11:12AM
09:09AM
09:00AM
Aug-16-23 11:06AM
10:21AM
Aug-15-23 10:32AM
Aug-14-23 11:31AM
10:32AM
Aug-11-23 10:07AM
07:03AM
Aug-10-23 08:05AM
07:58AM
Jul-31-23 08:36AM
Jul-21-23 11:30AM
Jul-17-23 09:40AM
08:17AM
07:05AM
Jul-09-23 04:04AM
Patterson Cos., Inc. engages in the provision of products, technologies, services, and business solutions to the dental and animal health markets. It operates through the following segments: Dental, Animal Health, and Corporate. The Dental segment provides consumable dental products, equipment and software, turnkey digital solutions, and value-added services to dentists, dental laboratories, institutions, and other healthcare professionals. The Animal Health segment distributes animal health products, services, and technologies to both the production-animal and companion-pet markets. The Corporate segment consists of general and administrative expenses, including home office support costs in areas such as information technology, finance, legal, human resources, and facilities. The company was founded by John Patterson and Myron Fayette Patterson in 1877 and is headquartered in St. Paul, MN.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
BARRY KEVIN MICHAEL Chief Financial Officer Dec 19 '23 Sale 27.18 560 15,221 21,674 Dec 19 04:46 PM Zurbay Donald President & CEO Dec 06 '23 Sale 26.58 1,868 49,651 141,923 Dec 07 05:18 PM BARRY KEVIN MICHAEL Chief Financial Officer Dec 01 '23 Sale 25.36 1,627 41,261 23,103 Dec 04 05:23 PM ROGAN TIMOTHY E President - Dental Oct 05 '23 Sale 29.75 9,260 275,525 40,382 Oct 06 04:47 PM Zurbay Donald President & CEO Jul 18 '23 Sale 32.48 5,620 182,553 149,539 Jul 19 05:01 PM KORSH LES B CLO & Corporate Secretary Jul 18 '23 Sale 32.47 3,686 119,686 78,095 Jul 19 05:00 PM Zurbay Donald President & CEO Jul 05 '23 Sale 32.34 1,666 53,878 143,819 Jul 06 02:56 PM KORSH LES B CLO & Corporate Secretary Jul 05 '23 Sale 32.34 908 29,365 74,265 Jul 06 02:58 PM KORSH LES B CLO & Corporate Secretary Jun 21 '23 Sale 31.75 3,500 111,125 67,949 Jun 23 12:23 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite